Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
Glial influence on the blood brain barrier.
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus.
Association of vitamin D and multiple sclerosis in India.
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
Epigenetics in NG2 glia cells.
Integrating the ICF with positive psychology: Factors predicting role participation for mothers with multiple sclerosis.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Neuroprotective effects of chrysin: From chemistry to medicine.
Pages
« first
‹ previous
…
331
332
333
334
335
336
337
338
339
…
next ›
last »